Market revenue in 2023 | USD 5,460.2 million |
Market revenue in 2030 | USD 9,903.7 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.99% in 2023. Horizon Databook has segmented the Mexico healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The introduction of the North American Free Trade Agreement (NAFTA) in the 1990s enabled U.S. firms to outsource manufacturing to Mexico through maquiladoras. Maquiladoras—duty-free factories— employed the Mexican labor force and were operated and/or owned by mainly U.S. firms, thus providing these companies access to skilled and low-cost labor.
The presence of maquiladoras in the country is anticipated to limit the adoption of contract manufacturing services in the country, especially by companies that have already matured or have reached the later stages of their business life cycle.
Nonetheless, availability of shelter programs, presence of skilled labor, and stringent intellectual property & socially responsible manufacturing laws are anticipated to drive the market. Proximity to the U.S. and Canada shortens the country’s supply chain to two of the leading countries in the industry, helping in the reduction of shipping costs.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Mexico healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account